D. Bitter‐Suermann

发表

Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping.

D. Suckau, J. Köhl, M. Przybylski, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids.

P. Lackie, D. Bitter‐Suermann, P. Komminoth, 1991, The American journal of pathology.

Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

D. Bitter‐Suermann, E. Böttger, U. Hadding, 1986, The Journal of clinical investigation.

NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.

K. Timmis, G. Boulnois, D. Bitter‐Suermann, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Immunocytochemical localization of enterobacterial common antigen in Escherichia coli and Yersinia enterocolitica cells

D. Bitter‐Suermann, H. Mayer, U. Meier-Dieter, 1986, Journal of bacteriology.

traT gene sequences, serum resistance and pathogenicity-related factors in clinical isolates of Escherichia coli and other gram-negative bacteria.

K. Timmis, D. Bitter‐Suermann, F. Cabello, 1985, Journal of general microbiology.

Embryonic neural cell adhesion molecules on human natural killer cells

D. Bitter‐Suermann, B. Fleischer, M. Husmann, 1989, European journal of immunology.

Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic bacteria, differentiating cells and tumor cells

D. Bitter‐Suermann, J. Roth, 1987, Immunologic research.

Polysialic acid units are spatially and temporally expressed in developing postnatal rat kidney.

D. Bitter‐Suermann, D. Taatjes, J. Roth, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Presence of the long chain form of polysialic acid of the neural cell adhesion molecule in Wilms' tumor. Identification of a cell adhesion molecule as an oncodevelopmental antigen and implications for tumor histogenesis.

D. Bitter‐Suermann, P. Heitz, J. Roth, 1988, The American journal of pathology.

An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues.

D. Bitter‐Suermann, C. Goridis, J. Finne, 1987, Journal of immunology.

Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor.

D. Bitter‐Suermann, C. Goridis, P. Heitz, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Chronic myelogenous leukemia‐derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a

A. Jeromin, J. Köhl, G. Rechkemmer, 1993, European journal of immunology.

Reevaluation of the C3a active site using short synthetic C3a analogues

J. Köhl, G. Karwath, D. Bitter‐Suermann, 1990, European journal of immunology.

Characterization of C3a receptor‐proteins on guinea pig platelets and human polymorphonuclear leukocytes

M. Casaretto, D. Bitter‐Suermann, R. Gerardy-Schahn, 1989, European journal of immunology.

Presence ofthe Long Chain Form ofPolysialic Acid

D. Bitter‐Suermann, P. Heitz, J. Roth, 2007 .

Serological study of meningococcal isolates in Switzerland and France 1980–1986

R. Auckenthaler, B. Hirschel, D. Bitter‐Suermann, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

Diagnostic use of monoclonal IgG antibody to meningococcal B polysaccharide in cerebrospinal fluid

D. Bitter‐Suermann, M. Frosch, W. Peuckert, 1986, Antonie van Leeuwenhoek.

Leydig cells express neural cell adhesion molecules in vivo and in vitro.

D. Bitter‐Suermann, M. Gratzl, A. Mayerhofer, 1992, Biology of reproduction.

Neural Cell Molecule Expression, Neuroendocrine Differentiation and Prognosis Lung Carcinoma in

O. Dalesio, S. Wagenaar, W. Mooi, 1991 .

Embryonic Neural Cell Adhesion Molecule in Cerebrospinal Fluid of Younger Children: Age‐Dependent Decrease During the First Year

D. Bitter‐Suermann, M. Frosch, M. Husmann, 1990, Journal of neurochemistry.

Immunohistochemical localization of polysialic acid in tissue sections: differential binding to polynucleotides and DNA of a murine IgG and a human IgM monoclonal antibody.

E. Kabat, D. Bitter‐Suermann, M. Frosch, 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Interaction of meningococcal group B monoclonal antibody and its Fab fragment with alpha 2-8-linked sialic acid polymers: requirement of a long oligosaccharide segment for binding.

D. Bitter‐Suermann, J. Finne, J. Häyrinen, 1989, Molecular immunology.

Differentiation‐regulated loss of the polysialylated embryonic form and expression of the different polypeptides of the neural cell adhesion molecule by cultured oligodendrocytes and myelin

J. Trotter, M. Schachner, D. Bitter‐Suermann, 1989, Journal of neuroscience research.

Evaluation of polysialic acid in the diagnosis of Wilms’ tumor

D. Bitter‐Suermann, P. Komminoth, P. Heitz, 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

Serotyping and genotyping of encapsulated Escherichia coli K1 sepsis isolates with a monoclonal IgG anti K1 antibody and K1 gene probes.

G. Boulnois, D. Bitter‐Suermann, I. Roberts, 1987, Microbial pathogenesis.

Molecular cloning and analysis of genes for production of K5, K7, K12, and K92 capsular polysaccharides in Escherichia coli

K. Timmis, G. Boulnois, R. Mountford, 1986, Journal of bacteriology.

Monoclonal antibodies to enterobacterial common antigen and to Escherichia coli lipopolysaccharide outer core: demonstration of an antigenic determinant shared by enterobacterial common antigen and E. coli K5 capsular polysaccharide

D. Bitter‐Suermann, H. Peters, K. Jann, 1985, Infection and immunity.

Surface components of Escherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes.

K. Timmis, G. Boulnois, D. Bitter‐Suermann, 1985, Current topics in microbiology and immunology.

Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution.

D. Bitter‐Suermann, P. Heitz, J. Roth, 1988, The American journal of pathology.

NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.

K. Timmis, G. Boulnois, D. Bitter‐Suermann, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of the C5a receptor on guinea pig platelets.

J. Köhl, D. Bitter‐Suermann, W. Bautsch, 1991, Immunobiology.

In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages

D. Bitter‐Suermann, U. Hadding, V. Brade, 1976, European journal of immunology.

Involvement of phospholipid metabolism in the events of the oxidative burst of granulocytes

D. Bitter‐Suermann, W. Englberger, U. Hadding, 1984, Agents and Actions.

Influence of lysophospholipids and PAF on the oxidative burst of PMNL.

D. Bitter‐Suermann, W. Englberger, U. Hadding, 1987, International journal of immunopharmacology.

Classical pathway of complement activation in mammalian kidneys.

G. Riethmüller, D. Bitter‐Suermann, R. Burger, 1993, Immunology.

Formation and function of a complement‐activating enzyme generated from factors of guinea pig serum and cobra venom

W. König, D. Bitter‐Suermann, M. Dierich, 1971, European journal of immunology.

Guillain‐barré syndrome

H. Hartung, K. Toyka, D. Bitter‐Suermann, 1987, Neurology.

Qualitative and quantitative determination of enterobacterial common antigen (ECA) with monoclonal antibodies: expression of ECA by two Actinobacillus species

D. Bitter‐Suermann, K. Wachsmuth, E. Böttger, 1987, Journal of clinical microbiology.

Hepatocellular carcinoma after thorotrast exposure: Establishment of a new cell line (Mz‐Hep‐1)

H. Dienes, W. Dippold, D. Bitter‐Suermann, 1985, Hepatology.

Biosynthesis of enterobacterial common antigen

D. Bitter‐Suermann, H. Mayer, P. D. Rick, 1985, Journal of bacteriology.

Quantitative determination of complement components produced by purified hepatocytes.

G. Ramadori, D. Bitter‐Suermann, R. Burger, 1984, Clinical and experimental immunology.

Linkage of total deficiency of the second component (C2) of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1981, Journal of immunology.

Biliary adenocarcinoma. Characterisation of three new human tumor cell lines.

W. Dippold, H. Gabbert, D. Bitter‐Suermann, 1985, Journal of hepatology.

Evaluation of low dose anaphylatoxic peptides in the pathogenesis of the adult respiratory distress syndrome (ARDS). Monitoring of early C5a effects in a guinea‐pig in vivo model after i.v. application **

D. Bitter‐Suermann, H. Baum, E. Böttger, 1986, European journal of clinical investigation.

Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.

H. Hartung, D. Bitter‐Suermann, U. Hadding, 1983, Journal of immunology.

Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion

D. Bitter‐Suermann, B. Zanker, U. Hadding, 1982, The Journal of experimental medicine.

LOW ZONE DESENSITIZATION: A STIMULUS-SPECIFI C CONTROL MECHANISM OF CELL RESPONSE Investigations on Anaphylatoxin-in duced

D. Bitter‐Suermann, B. Zanker, U. Hadding, 1982 .

Impaired humoral immune response in complement C3‐deficient guinea pigs: absence of secondary antibody response

D. Bitter‐Suermann, R. Burger, E. Böttger, 1986, European journal of immunology.

Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.

J. Lambris, A. Theofilopoulos, D. Bitter‐Suermann, 1985, The Journal of clinical investigation.

Inherited polymorphism of guinea pig factor B and C4: evidence for genetic linkage between the C4 and Bf loci.

D. Bitter‐Suermann, M. Krönke, U. Hadding, 1977, Journal of immunology.

Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis.

D. Bitter‐Suermann, M. Frosch, T. Pfister, 1991, Molecular and biochemical parasitology.

Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a)

R. Andreatta, D. Bitter‐Suermann, U. Hadding, 1981, Inflammation.

Comparative study on biological effects of the guinea pig complement-peptide C3a and C3a-related synthetic oligopeptides.

R. Andreatta, D. Bitter‐Suermann, S. Becker, 1980, Molecular immunology.

The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.

D. Bitter‐Suermann, S. Becker, U. Hadding, 1978, Zeitschrift fur Immunitatsforschung. Immunobiology.

Stimulation of prostaglandin E and thromboxane synthesis in macrophages by purified C3b.

H. Hartung, D. Bitter‐Suermann, D. Gemsa, 1983, Journal of immunology.

Epidemiology of meningococcal disease in Switzerland, 1980–1986:Using monoclonal antibodies to classify disease-related isolates

R. Auckenthaler, B. Hirschel, D. Bitter‐Suermann, 1988 .

Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.

S. Batsford, A. Vogt, D. Bitter‐Suermann, 1991, Laboratory investigation; a journal of technical methods and pathology.

Suppressive effects of C3b on monocyte‐dependent T cell proliferation

S. Meuer, D. Bitter‐Suermann, U. Hadding, 1987, European journal of immunology.

Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.

D. Bitter‐Suermann, M. Loos, 1976, Immunology.

Virus‐Transformed Macrophage‐Like Cell Line as Tool for Eicosanoid Research

K. Resch, W. Ostertag, D. Bitter‐Suermann, 1989, Journal of leukocyte biology.

Comparison of the antibacterial effect of uroepithelial cells from healthy donors and children with asymptomatic bacteriuria

D. Bitter‐Suermann, H. Schulte-Wissermann, F. Zepp, 1985, European Journal of Pediatrics.

Primary structure of the murine monoclonal IgG2a antibody mAb735 against alpha (2-8) polysialic acid. 2. Amino acid sequence of the heavy (H-) chain Fd' region.

N. Hilschmann, D. Bitter‐Suermann, M. Frosch, 1993, Biological chemistry Hoppe-Seyler.

Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

D. Bitter‐Suermann, J. Hamuro, U. Hadding, 1978, Immunology.

Synthetic C3a analogs as specific inhibitors of C3a activity.

R. Andreatta, D. Bitter‐Suermann, U. Hadding, 1981, Immunopharmacology.

“ Monorail technique or external fixators for segmental bone defects of the lower limb ? Long term follow-up of 50 cases

D. Bitter‐Suermann, G. Lewinski, S. Hankemeier, 2010 .

Enhanced biopotency of synthetic C3a analogues by membrane binding. A fluorescence anisotropy decay study.

M. Federwisch, D. Bitter‐Suermann, R. Gerardy-Schahn, 1992, Biophysical chemistry.

Ability of the T cell‐replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation

W. König, D. Bitter‐Suermann, M. Dierich, 1973, European journal of immunology.

Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1975, Immunology.

An in vitro system to study listericidal capacity of macrophages from separate mice: resident macrophages exhibit different activation patterns

D. Bitter‐Suermann, U. Hadding, D. Ottendorfer, 1985, Infection and immunity.

Expression of Ia antigens on macrophages is reduced after stimulation with homologous C3b.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1984, Journal of immunology.

Interactions between Mycoplasma pneumoniae and guinea pig complement

D. Bitter‐Suermann, W. Bredt, 1975, Infection and immunity.

Biosynthesis of the third (C3), eighth (C8), and ninth (C9) complement components by guinea pig hepatocyte primary cultures.

G. Ramadori, D. Bitter‐Suermann, Francesco Saverio Tedesco, 1985, Immunobiology.

A safe and efficient method for elimination of cell culture mycoplasmas using ciprofloxacin.

D. Bitter‐Suermann, U. Hadding, W. Däubener, 1988, Journal of immunological methods.

Effects of basic Fibroblast Growth Factor ( bFGF ) on viability , proliferation , and bcl-2 expression in Multiple Myeloma

K. Welte, D. Bitter‐Suermann, 2019 .

Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma.

O. Dalesio, S. Wagenaar, N. van Zandwijk, 1991, European journal of cancer.

The Complement System

D. Bitter‐Suermann, G. Till, K. Rother, 1988, Springer Berlin Heidelberg.

Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1982, Journal of immunology.

Guinea pigs deficient in C2, C4, C3 or the C3a receptor.

D. Bitter‐Suermann, R. Burger, 1986, Progress in allergy.

COMPLEMENT-DEPENDENT B-CELL ACTIVATION BY COBRA VENOM FACTOR AND OTHER MITOGENS?

W. König, D. Bitter‐Suermann, M. Dierich, 1974, The Journal of experimental medicine.

Cyclic disulfide analogues of the complement component C3a. Synthesis and conformational investigations.

H. Höcker, D. Bitter‐Suermann, A. Wollmer, 2009, International journal of peptide and protein research.

Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

D. Bitter‐Suermann, A. Allison, H. Schorlemmer, 1977, Immunology.

Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs.

D. Bitter‐Suermann, E. Böttger, U. Hadding, 1985, Journal of immunology.

Platelet-serotonin release by C3a and C5a: two independent pathways of activation.

D. Bitter‐Suermann, U. Hadding, S. Meuer, 1981, Journal of immunology.

Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.

W. König, D. Bitter‐Suermann, M. Dierich, 1972, Immunology.

Interaction of macrophages and synthetic polyanions in the inflammatory response

D. Bitter‐Suermann, U. Hadding, H. Schorlemmer, 1980 .

Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release

H. Hartung, D. Bitter‐Suermann, U. Hadding, 1982, European journal of immunology.

Sandwich enzyme-linked immunosorbent assays for the quantification of the C4 isotypes (C4A and C4B) in human plasma.

D. Bitter‐Suermann, C. Rittner, S. Bank, 1989, Journal of immunological methods.

Bypass-activation of the complement system starting with C3. II. C3-activation by gamma-1-immune aggregates in guinea pig serum.

W. König, D. Bitter‐Suermann, M. Dierich, 1973, Immunochemistry.

Interaction of amphiphilic polymers with model membranes

H. Ringsdorf, J. Venzmer, D. Bitter‐Suermann, 1989 .

ACTIVATION OF COMPLEMENT BY THE ALTERNATIVE PATHWAY AS A FACTOR IN THE PATHOGENESIS OF PERIODONTAL DISEASE

D. Bitter‐Suermann, A. Allison, H. Schorlemmer, 1976, The Lancet.

C3-Dependence of B-Cell Activation?

W. König, D. Bitter‐Suermann, M. Dierich, 1973, Journal of Immunology.

Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system.

D. Bitter‐Suermann, M. Dierich, U. Hadding, 1975, Journal of immunology.

Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.

D. Bitter‐Suermann, U. Hadding, F. Melchert, 1970, Immunochemistry.

The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs.

D. Bitter‐Suermann, E. Böttger, U. Hadding, 1986, Journal of immunology.

Independent and consecutive action of C5, C6 and C7 in immune hemolysis. II. Formation and decay of the intermediate complexes EAC1-5 and EAC1-6.

D. Bitter‐Suermann, U. Hadding, H. Wellensiek, 1970, Immunochemistry.

Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.

D. Bitter‐Suermann, A. Klos, M. Messner, 1988, Journal of immunological methods.

Inflammation-Promoting Complement Fragments

J. Köhl, D. Bitter‐Suermann, 1989 .

Mediator systems in a passive model of in situ immune complex glomerulonephritis. Role for complement, polymorphonuclear granulocytes and monocytes.

S. Batsford, F. Thaiss, A. Vogt, 1986, Laboratory investigation; a journal of technical methods and pathology.

Cell surface antigens on the guinea-pig macrophage: identification by monoclonal antibodies and association with the activation state.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1985, Immunology.

Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements.

D. Bitter‐Suermann, R. Gerardy-Schahn, A. Wollmer, 1988, The Biochemical journal.

Complement system promotes transfer of immune complex across glomerular filtration barrier.

S. Batsford, A. Vogt, D. Bitter‐Suermann, 1995, Laboratory investigation; a journal of technical methods and pathology.

Interaction of C3b, B, and D in the alternative pathway of complement activation.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1975, Journal of immunology.

Combination of rRNA-Targeted Hybridization Probes and Immuno-Probes for the Identification of Bacter

R. Amann, D. Bitter‐Suermann, I. Steinmetz, 1996 .

Rapid determination of members of the family Enterobacteriaceae in drinking water by an immunological assay using a monoclonal antibody against enterobacterial common antigen

D. Bitter‐Suermann, U. Obst, I. Hübner, 1992, Applied and environmental microbiology.

Expression of the Escherichia coli K5 capsular antigen: immunoelectron microscopic and biochemical studies with recombinant E. coli

G. Boulnois, D. Bitter‐Suermann, I. Roberts, 1990, Journal of bacteriology.

Immunocytological localization of the highly polysialylated form of the neural cell adhesion molecule during development of the murine cerebellar cortex

M. Schachner, D. Bitter‐Suermann, A. Hekmat, 1990, The Journal of comparative neurology.

Interaction of Ross River virus with the complement system.

D. Bitter‐Suermann, J. Aaskov, U. Hadding, 1985, The Journal of general virology.

Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency.

W. König, D. Bitter‐Suermann, E. Rietschel, 1973, Immunology.

Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A.

D. Bitter‐Suermann, M. Dierich, M. Loos, 1974, Journal of immunology.

Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.

D. Bitter‐Suermann, U. Hadding, V. Brade, 1974, Journal of immunology.

Human C5a anaphylatoxin: gene cloning and expression in Escherichia coli.

D. Suckau, J. Köhl, D. Bitter‐Suermann, 1992, Immunobiology.

Activation of the alternative pathway of complement: inhibition by low molecular weight polyanions.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1978, Immunochemistry.

Insoluble polyanions as activators of both pathways of complement.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1977, Immunology.

Mouse factor B of the alternative pathway of complement activation. I. Purification, characterization, and functional behavior.

D. Bitter‐Suermann, R. Burger, U. Hadding, 1976, Journal of immunology.

Factor D in the alternate pathway of complement activation: purification, physicochemical characterization and functional role.

W. König, D. Bitter‐Suermann, M. Dierich, 1974, Immunochemistry.

DNP-antigens activate the alternate pathway of the complement system.

W. König, D. Bitter‐Suermann, M. Dierich, 1974, Journal of immunology.

Activation of the alternative pathway of complement: efficient fluid‐phase amplification by blockade of the regulatory complement protein β1H through sulfated polyanions

D. Bitter‐Suermann, R. Burger, U. Hadding, 1981, European journal of immunology.

Giant liposomes as model membranes for immunological studies: spontaneous insertion of purified K1-antigen (poly-alpha-2,8-NeuAc) of Escherichia coli.

H. Ringsdorf, J. Venzmer, D. Bitter‐Suermann, 1990, Biochimica et biophysica acta.

In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.

D. Bitter‐Suermann, H. Baum, E. Böttger, 1988, Clinical and experimental immunology.

Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212.

C. Figdor, R. Michalides, D. Bitter‐Suermann, 1990, Cancer research.

Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H.

H. Hartung, D. Bitter‐Suermann, D. Gemsa, 1984, Clinical and experimental immunology.

Killing of tumor cells in vitro by macrophages from mice treated with synthetic dehydrodipeptides.

D. Bitter‐Suermann, U. Hadding, H. Schorlemmer, 1979, Cancer Research.

Influence of macrophage activation on the synthesis of complement components C2, C3, C4.

H. Hartung, D. Bitter‐Suermann, B. Zanker, 1982, Advances in experimental medicine and biology.

Expression of the embryonal neural cell adhesion molecule N‐CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non‐small cell lung cancer

W. Mooi, R. Michalides, D. Bitter‐Suermann, 1989, The Journal of pathology.

Up-regulation of embryonic NCAM in an EC cell line by retinoic acid.

D. Bitter‐Suermann, M. Husmann, I. Görgen, 1989, Developmental biology.

An inherited deficiency of the third component of complement, C3, in guinea pigs

J. Gordon, D. Bitter‐Suermann, B. Zanker, 1986, European journal of immunology.

Monoclonal antibody detection of IncF group plasmid-encoded TraT protein in clinical isolates of Escherichia coli

D. Bitter‐Suermann, H. Peters, K. Timmis, 1984, Infection and immunity.

Platelet Activation: a New Biological Activity of Guinea‐pig C3a Anaphylatoxin

D. Bitter‐Suermann, S. Becker, U. Hadding, 1978, Scandinavian journal of immunology.

C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.

D. Bitter‐Suermann, B. Zanker, H. Rasokat, 1982, Agents and actions. Supplements.

Genus-specific epitope on the 60-kilodalton Legionella heat shock protein recognized by a monoclonal antibody

D. Bitter‐Suermann, I. Steinmetz, C. Rheinheimer, 1991, Journal of clinical microbiology.

Effect of in vivo stimulation of mice on the secretion of factor B of the alternative complement pathway by peritoneal macrophages

D. Bitter‐Suermann, U. Hadding, V. Brade, 1977, European journal of immunology.

Rapid identification of legionellae by a colony blot assay based on a genus-specific monoclonal antibody

D. Bitter‐Suermann, I. Steinmetz, C. Rheinheimer, 1992, Journal of clinical microbiology.

Primary structure of the murine monoclonal IgG2a antibody mAb735 against alpha(2-8) polysialic acid. 1) Amino-acid sequence of the light (L-) chain, kappa-isotype.

N. Hilschmann, D. Bitter‐Suermann, K. Eckart, 1991, Biological chemistry Hoppe-Seyler.

Demonstration of High‐Affinity Binding Sites for C3a Anaphylatoxin on Guinea‐Pig Platelets

D. Bitter‐Suermann, S. Becker, U. Hadding, 1978, Scandinavian journal of immunology.

Linkage of C4 and C4 deficiency to BF and GPLA

D. Bitter‐Suermann, M. Krönke, U. Hadding, 1977, Immunogenetics.

Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212.

C. Figdor, R. Michalides, D. Bitter‐Suermann, 1990, Cancer research.

DNA probes for K-antigen (capsule) typing of Escherichia coli

P. Williams, G. Boulnois, D. Bitter‐Suermann, 1988, Journal of clinical microbiology.

Inhibition of interleukin 3 function by a fragment of the third component of complement

D. Bitter‐Suermann, E. Schmitt, U. Hadding, 1987, European journal of immunology.

Physicochemical characterization of the fifth (C5), sixth (C6), seventh (C7), eighth (C8) and ninth (C9) component of guinea pig complement

W. König, D. Bitter‐Suermann, M. Dierich, 1971, European journal of immunology.

A Tool for the Detection of C'6 Deficiencies

D. Bitter‐Suermann, U. Hadding, F. Melchert, 1970 .

Enzymatic Activation of C3 by a Complex Derived from a Purified Cobra Venom Factor and a Serum Globulin

W. König, D. Bitter‐Suermann, M. Dierich, 1971, The Journal of Immunology.

Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.

D. Bitter‐Suermann, U. Hadding, V. Brade, 1977, Zeitschrift fur Immunitatsforschung. Immunobiology.